Comparison of Cost-minimization Analyses between Metformin and Acarbose Combined with Insulin in Treating Type2Diabetes Mellitus
- VernacularTitle:二甲双胍与阿卡波糖分别联合胰岛素治疗2型糖尿病的最小成本分析
- Author:
Zhigao HE
;
Li JIN
- Publication Type:Journal Article
- Keywords:
Type2diabetes mellitus;
Metformin;
Acarbose;
Insulin;
Cost-minimization analysis
- From:
China Pharmacy
2001;0(10):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To compare the effects and costs between metformin and acarbose when combined with insulin in treating type2diabetes mellitus.METHODS:Cost-minimization analysis in medical economy was applied to analyze the therapeutic effects,costs and cost related factors with the respect for the patients.RESULTS:There was no statistically sig?nificant difference in effects of the2therapeutic regimens.Total cost and drug cost per head in metformin group were1941.46yuan and138.86yuan respectively as compared with2308.37yuan and229.82yuan respectively in acarbose group.The analysis on cost related factors showed no statistical significance.CONCLUSION:Metformin combined with insulin is a preferable therapeutic regimen.
